LM11A-31, non-peptide, a small-molecule p75NTR modulator, show excellent blood–brain barrier penetration and tolerability and mitigates pathology in models of Alzheimer’s disease, Huntington’s disease and TBI injury. The gene discussed is NGFR; the disease is juvenile Huntington disease.